Common GLP-1 Agonists Here is a list of some of the most common GLP-1 medications approved by the FDA: For Type 2 Diabetes: Adlyxin (lixisenatide) Ozempic (semaglutide) Rybelsus (semaglutide, oral tablet) Trulicity (dulaglutide) Victoza (liraglutide) Combination medications like Soliqua Vial (lixisenatide and insulin glargine) For Obesity: Saxenda (liraglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Numerous other states are considering adding these medications because of the potential benefits of reducing obesity and the health complications it may prompt
Mounjaro's primary mechanism of action targets blood glucose regulation through hormonal pathways, not the blood clotting system
(2006) also reported a 50%-200% increase in IGF-1 for about 10 days following a CJC-1295 injection at a dose between 30-250mcg/kg [15] In addition, preclinical experiments involving longer administration periods report that the peptide can have significant benefits for growth and body composition
References Wang JY, Wang QW, Yang XY, et al
Doctors prescribe it for things like epilepsy, nerve pain, and sometimes anxiety